GABAA receptors reorganize when layer 4 in ferret somatosensory cortex is disrupted by methylazoxymethanol (MAM).
We established a model of cortical development that arrests the birth of layer 4 cells by injecting methylazoxymethanol (MAM) on embryonic day 33 (E33) in ferrets. This leads to adult somatosensory cortex with a very thin layer 4. Earlier, we determined the relative absence of layer 4 changed the growth and differentiation of the somatosensory cortex and the growth of thalamic afferents into the cortical plate. To identify other features of cortical organization that might be altered after MAM treatment, we assessed the distribution of selected excitatory and inhibitory receptors in area 3b of ferret somatosensory cortex. Initial screening revealed the distribution of several excitatory receptors (NMDA, AMPA, kainate) in E33 MAM-treated cortex was similar to that in normal adult animals. In contrast, the binding pattern of inhibitory GABAA receptors was altered in MAM-treated cortex. Normally, GABAA receptors densely locate in central layers of cortex. In E33 MAM-treated animals, GABAA receptor binding extended superficially, covering a broader area of cortex. Further experiments using antibodies directed against GABAAalpha receptors disclosed that pan alpha GABAA receptors strongly localize to layer 4 in normal area 3b. In E33 MAM-treated cortex, however, GABAAalpha receptors extend outside and are located above and below the very thin layer 4. The redistribution of inhibitory receptors suggests that layer 4 plays an important role in regulating thalamic terminations and also in the resulting ability to refine processing of incoming stimuli.
Jablonska
Beata
B
Department of Anatomy, Physiology and Genetics, USUHS, Bethesda, MD 20814, USA.
Smith
Adam L
AL
Palmer
Sidney L
SL
Noctor
Stephen C
SC
Juliano
Sharon L
SL
D000818:Animals; D001345:Autoradiography; D005260:Female; D005289:Ferrets / Q000502:physiology*; D007150:Immunohistochemistry; D008746:Methylazoxymethanol Acetate / Q000031:analogs & derivatives* / Q000633:toxicity*; D009412:Nerve Fibers / Q000502:physiology; D009475:Neurons, Afferent / Q000502:physiology; D011247:Pregnancy; D018091:Receptors, AMPA / Q000502:physiology; D011963:Receptors, GABA-A / Q000187:drug effects* / Q000502:physiology*; D018092:Kainic Acid Receptors / Q000502:physiology; D016194:Receptors, N-Methyl-D-Aspartate / Q000502:physiology; D013003:Somatosensory Cortex / Q000166:cytology / Q000187:drug effects* / Q000502:physiology*; D013788:Thalamus / Q000166:cytology / Q000502:physiology
D008746:Methylazoxymethanol Acetate; D018091:Receptors, AMPA; D011963:Receptors, GABA-A; D018092:Kainic Acid Receptors; D016194:Receptors, N-Methyl-D-Aspartate; C030667:methylazoxymethanol